Sign in to continue:

Friday, February 13th, 2026

JD Health International Inc: Technical Buy with Promising Upside Targets

Date of Report: September 25, 2024
Broker: CGS International Securities


Stock Overview

Company Name: JD Health International Inc
Stock Code: 6618
Last Price: 26.75

Investment Recommendation

JD Health International Inc is identified as a Technical Buy in the report with the following entry price levels and targets:

Entry Prices:

  • 26.75
  • 23.84
  • 21.60

Stop Loss:

  • 19.35

Target Prices

The report outlines multiple target prices for JD Health International Inc:

  • Target 1: 31.60
  • Target 2: 36.30
  • Target 3: 40.00
  • Target 4: 45.40

These targets indicate a strong potential for growth and are appealing for investors looking for significant returns.


Technical Indicators and Analysis

JD Health International Inc is recommended for technical buying based on the following factors:

  • The stock’s last price is listed at 26.75, with several upward target price levels indicating potential gains.
  • A stop loss is recommended at 19.35, providing a safeguard for investors.

The report highlights that the stock is showing positive technical signals, making it an attractive option for those focused on technical market analysis.

Main Beneficiaries from the MAS Boost

Main Beneficiaries from the MAS Boost 1.) 💹 Singapore’s S$5 Billion Equities Power-Up: Who Stands to Gain Most? SGX:D05.SI:DBS Group Singapore’s leading bank is poised to benefit from increased trading and fund inflows prompted by...

Haw Par Corp : Long Entry at 10.90, with a Target of 11.30,

Haw Par Corp Ltd. (HPAR SP) Current Performance: Shares closed at a 52-week high, indicating strong momentum in the stock price. Volume has also increased, which suggests greater market interest and support for the...

Singapore Market Outlook 2026 – Equity Trends, Top Stocks & Global Insights from OCBC Research 24

Broker Name: OCBC Group Date of Report: 5 January 2026 Excerpt from OCBC Group report Report Summary: Global equity markets ended 2025 with strong gains, marking the third consecutive year of positive returns, fueled...